These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18391616)

  • 21. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy.
    Merle P; Mornex F; Trepo C
    Cancer Lett; 2009 Dec; 286(1):129-33. PubMed ID: 19138819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma (HCC): current and evolving therapies.
    Gish RG; Baron A
    IDrugs; 2008 Mar; 11(3):198-203. PubMed ID: 18311657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [External radiotherapy for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report.
    Sotiropoulos GC; Hilgard P; Antoch G; Nowak KM; Ertl J; Fouzas I; Molmenti EP; Sgourakis G; Beckebaum S; Paul A; Broelsch CE; Lang H
    Transplant Proc; 2008 Dec; 40(10):3804-5. PubMed ID: 19100496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combating hepatocellular carcinoma with an integrated approach.
    Ho S; Johnson PJ; Leung WT; Lau WY
    Chin Med J (Engl); 1999 Jan; 112(1):80-3. PubMed ID: 11593648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
    Bal CS; Kumar A
    Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.
    Van De Wiele C; Defreyne L; Peeters M; Lambert B
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):317-24. PubMed ID: 19521311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
    Tian G; Liu J; Zhou JS; Chen W
    Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?
    Dawson LA
    Semin Radiat Oncol; 2011 Oct; 21(4):241-6. PubMed ID: 21939852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
    Riaz A; Lewandowski RJ; Kulik L; Salem R
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.